Intuitive Surgical, Inc. $ISRG Shares Sold by New York Life Investment Management LLC

New York Life Investment Management LLC reduced its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.5% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 52,361 shares of the medical equipment provider’s stock after selling 1,345 shares during the quarter. New York Life Investment Management LLC’s holdings in Intuitive Surgical were worth $23,417,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in ISRG. Tobam boosted its position in shares of Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 40 shares during the last quarter. Kilter Group LLC acquired a new position in Intuitive Surgical during the second quarter worth approximately $27,000. Greykasell Wealth Strategies Inc. purchased a new position in Intuitive Surgical during the third quarter worth approximately $27,000. Princeton Global Asset Management LLC acquired a new position in shares of Intuitive Surgical in the 2nd quarter valued at $30,000. Finally, Guerra Advisors Inc purchased a new stake in shares of Intuitive Surgical during the 3rd quarter valued at $37,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts recently weighed in on the company. Sanford C. Bernstein increased their target price on Intuitive Surgical from $740.00 to $750.00 and gave the stock an “outperform” rating in a research report on Friday, January 23rd. Mizuho set a $575.00 price objective on Intuitive Surgical in a report on Wednesday, October 22nd. Truist Financial lifted their price objective on Intuitive Surgical from $620.00 to $650.00 and gave the company a “buy” rating in a research note on Thursday, December 18th. Evercore dropped their target price on shares of Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating for the company in a research report on Friday, January 23rd. Finally, Jefferies Financial Group raised their price target on shares of Intuitive Surgical from $550.00 to $560.00 and gave the company a “hold” rating in a report on Wednesday, October 22nd. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $617.23.

Intuitive Surgical Stock Performance

ISRG stock opened at $488.15 on Monday. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $609.08. The firm has a market cap of $173.36 billion, a P/E ratio of 61.87, a price-to-earnings-growth ratio of 3.79 and a beta of 1.65. The stock has a 50-day simple moving average of $549.63 and a 200-day simple moving average of $510.60.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping the consensus estimate of $2.27 by $0.26. The firm had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.Intuitive Surgical’s revenue for the quarter was up 18.8% on a year-over-year basis. During the same period in the previous year, the company posted $2.21 EPS. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insiders Place Their Bets

In related news, SVP Mark Brosius sold 4,500 shares of the firm’s stock in a transaction on Friday, December 12th. The shares were sold at an average price of $547.36, for a total transaction of $2,463,120.00. Following the completion of the sale, the senior vice president directly owned 907 shares of the company’s stock, valued at approximately $496,455.52. This trade represents a 83.23% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Henry L. Charlton sold 13,731 shares of the business’s stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the completion of the transaction, the executive vice president owned 3,056 shares in the company, valued at $1,772,480. This represents a 81.80% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 70,011 shares of company stock valued at $38,858,275. Corporate insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.